jinfukang

09/06/2016 - "In this study, we examined the effect of Jinfukang (JFK), an effective herbal medicine against lung cancer, on DDP-induced cytotoxicity in lung cancer cells. "
03/01/2021 - "These data suggest that Jinfukang exerts anti-metastatic effects in lung cancer may through anoikis."
06/28/2020 - "Jinfukang has long been used for the clinical treatment of lung cancer. "
01/01/2017 - "Genome-Wide Profiling Reveals That Herbal Medicine Jinfukang-Induced Polyadenylation Alteration Is Involved in Anti-Lung Cancer Activity."
01/01/2017 - "Bone Marrow Derived Mesenchymal Stem Cells Involve in the Lymphangiogenesis of Lung Cancer and Jinfukang Inhibits the Involvement In Vivo."

07/15/2021 - "To explore the anti-metastasis mechanism of Jinfukang from the perspective of regulating NK cells to clear CTCs. "
07/15/2021 - "Yet, whether Jinfukang prevents metastasis by regulating immune cells to clearance CTCs is still unknown. "
07/15/2021 - "The above effects of Jinfukang could be partially reversed by an anti-CX3CL1 mAb. These results suggest that Jinfukang may prevent lung cancer metastasis by enhancing the clearance of CTCs in the peripheral blood by NK cells, providing evidence for the anti-metastasis effect of Jinfukang."
01/10/2024 - "Clinical studies have proven that Jinfukang (JFK) can effectively treat lung cancer metastasis by regulating T lymphocytes. "
03/01/2021 - "Previous studies have shown that Jinfukang could prevent the recurrence and metastasis of lung cancer, and we have established a circulating lung tumor cell line CTC-TJH-01. "

01/01/2017 - "Furthermore, Jinfukang treatment resulted in a significant reduction of the average weight of the tumor mass in chimeric mice, and displayed a significant lower number of LYVE-1 positive cells. "
08/07/2019 - "In this study, we investigated the action and underlying mechanisms of Jinfukang against circulating lung tumor cells. "
01/01/2023 - "Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway."
01/01/2017 - "Jinfukang inhibits the lung tumor mass via suppression of the BMMSCs transformation and lung tumor lymphangiogenesis. "
07/16/2021 - "Jinfukang is a commonly used traditional Chinese medicine preparation with anti-tumor effect in China, which has been approved by China Food and Drug Administration against NSCLC. "

06/28/2020 - "Previous studies have shown that Jinfukang can induce the apoptosis of circulating tumor cells by intervening ROS-mediated DNA damage pathway. "
06/28/2020 - "However, whether Jinfukang can inhibit the metastasis of circulating tumor cells and its mechanism are still unclear. "
06/28/2020 - "Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer."

01/01/2017 - "Jinfukang has clinically been used for the treatment of non small cell lung cancer (NSCLC) in China. "
07/16/2021 - "Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients?: A protocol for a double-blind, randomized controlled trial."
08/07/2019 - "The traditional Chinese medicine, Jinfukang, has been clinically available for the treatment of non-small cell lung cancer (NSCLC). "
10/01/2018 - "The traditional Chinese medicine Jinfukang (JFK) has been shown as a valuable drug to treat non-small cell lung cancer (NSCLC). "